Stage III Grade 3 Follicular Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Carmustine (DB00262)

IndicationStatusPhase
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01035463Lenalidomide Maintenance Therapy After High Dose BEAM With or Without RituximabTreatment